Gregory L. Summe to Serve as Next Chairman of the Board Beginning on January 1, 2026 Jonathan Peacock to Step Down After Nearly Nine Years of Dedicated Service to the Board RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology […]
Lausanne, Switzerland and Frederick, MD – Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models. This advancement extends Alithea’s MERCURIUS DRUG-seq technology into physiologically relevant 3D systems, bringing simplicity, sensitivity, and throughput to drug […]
Physician-scientist with experience spanning biomarker development and regulatory submissions joins to expand Tapestri’s reach to guide therapeutic insights SOUTH SAN FRANCISCO, Calif. — Mission Bio, a leader in single-cell multi-omics for precision medicine, today announced the appointment of Zivjena Vucetic, M.D., Ph.D., as Chief Medical Officer. A physician-scientist with more than 15 years of experience […]
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the District Court for the District of Delaware has granted Parse’s Motion for Summary Judgment of Invalidity for Scale Biosciences’ 11,634,752 patent. The Court concluded that the claims of the ‘752 patent were invalid for lack of […]
Advancing multi-omics research by enabling Tempus’ data-driven expertise with Parse’s scalable single cell platform Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome Tempus as the newest member of its Certified Service Provider (CSP) Program. Together, the companies will broaden access to high-quality and scalable single cell and empower […]
BOSTON–Atrandi Biosciences, a pioneering life sciences company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology, will present its latest developments at the American Society of Human Genetics (ASHG) 2025 Annual Meeting, taking place October 14–18 in Boston. Attendees are invited to explore how SPCs are reshaping single-cell multiomics at booth #2402. “The Atrandi […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboration. Together, BD and Opentrons will integrate robotic liquid-handling capabilities into BD single-cell multiomics instruments, automating critical […]
Takara Bio USA, Inc. (“Takara Bio USA”), a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology. Takara Bio USA has expanded its instrument-free Trekker™ Single-Cell Spatial Mapping Kits for compatibility with formalin-fixed […]
FREDERICK, Md. and PLANO, Texas — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01. In March 2025, […]
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva (Global Life Sciences Solutions USA, LLC), a Danaher company and a global leader in the life sciences industry, will lead a new effort aiming to […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
